Li Liu

Title: Innovations of Li Liu in Cardiac Muscle Cell Research

Introduction

Li Liu is an accomplished inventor based in Kyoto, Japan. He has made significant contributions to the field of cardiac muscle cell research, particularly through his innovative methods for producing specific proteins in these cells. With a total of two patents to his name, Liu's work is paving the way for advancements in regenerative medicine.

Latest Patents

Li Liu's latest patents include a method for efficiently producing β myosin heavy chain in cardiac muscle cells differentiated from induced pluripotent stem cells derived from Homo sapiens. This invention outlines a process where a liquid culture medium containing cardiac muscle cells is supplied onto a substrate with electrodes and insulative fibers. The method involves applying a pulse electric current to cultivate the cardiac muscle cells effectively. Another notable patent is for an active-ester-group-containing composition for producing fibers, which includes a polymer compound, a crosslinking agent, an acid compound, and a solvent. This composition is crucial for developing cell culture scaffold materials.

Career Highlights

Throughout his career, Li Liu has worked with prominent companies such as Panasonic Corporation and Nissan Chemical Industries Limited. His experience in these organizations has contributed to his expertise in the field of biotechnology and materials science.

Collaborations

Li Liu has collaborated with notable coworkers, including Kiyotaka Tsuji and Makiko Umezaki. Their combined efforts have furthered research and development in cardiac muscle cell applications.

Conclusion

Li Liu's innovative patents and career achievements highlight his significant role in advancing cardiac muscle cell research. His contributions are essential for future developments in regenerative medicine and biotechnology.